Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in kids and grown-ups . In Canada, its distribution is managed by Health Canada. This https://teva-lisdexamfetamine-fo488817.imblogs.net/93089542/this-medication-in-canada-a-complete-guide